Evidence map›Paper›PMID 28884421›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2018

Assessing responsiveness over time of the PROMIS

Bryce B Reeve, Lloyd J Edwards, Byron C Jaeger, Pamela S Hinds, Carlton Dampier, Debbie S Gipson, David T Selewski, Jonathan P Troost, David Thissen, Vaughn Barry and 2 more

Open access · greenAbstract read
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Vitamin D Supplementation Improves Health-Related Quality of Life and Physical Performance in Children with Sickle Cell Disease and in Healthy Children.Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners
    Trial
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Patient-Reported Outcomes in Pediatric Patients With Cancer.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Bryce B ReeveLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. bbreeve@email.unc.edu.
Lloyd J EdwardsDepartment of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.
Byron C JaegerDepartment of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.
Pamela S HindsDepartment of Nursing Research and Quality Outcomes, Children's National Health System, Washington, DC, USA.
Carlton DampierDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Debbie S GipsonC.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA.
David T SelewskiC.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA.
Jonathan P TroostC.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, USA.
David ThissenDepartment of Psychology and Neuroscience, University of North Carolina, Chapel Hill, NC, USA.
Vaughn BarryDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Heather E GrossLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Darren A DeWaltDivision of General Medicine and Clinical Epidemiology, UNC School of Medicine, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · USUniversity of Michigan–Ann Arbor · USChildren's Healthcare of Atlanta · USChildren's National · USC. S. Mott Children's Hospital · USEmory University · USUNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina Health Care · US

Funding

The National Person-Centered Assessment Resource (PCAR)U2CCA186878 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GERSHON, RICHARD · 2014 to 2018
$11.9M
NIH PROMIS Statistical Coordinating Center(RMI)U01AR052177 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CELLA, DAVID · 2004 to 2010
$10.6M
Validating and Extending the PROMIS Sexual Function Measure for Clinical ResearchU01AR052186 · NIAMS · DUKE UNIVERSITY · PI WEINFURT, KEVIN P · 2004 to 2013
$9.5M
PROMIS Pediatrics: Longitudinal Validation and Linking Pediatric and Adult Item BU01AR052181 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI REEVE, BRYCE B · 2004 to 2013
$9.1M
Patient reported outcomes in routine clinical care of patients infected with HIVU01AR057954 · NIAMS · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., CRANE, PAUL K · 2009 to 2013
$7.8M
Validation and domain development in mental health and sleep-wake functionU01AR052155 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PILKONIS, PAUL A · 2004 to 2013
$6.0M
Validation of PROMIS in Diverse Cancer PopulationsU01AR057971 · NIAMS · GEORGETOWN UNIVERSITY · PI MOINPOUR, CAROL M, POTOSKY, ARNOLD L · 2009 to 2013
$5.7M
Improving Assessment of Physical Function and Drug Safety in Health and DiseaseU01AR052158 · NIAMS · STANFORD UNIVERSITY · PI KRISHNAN, ESWAR · 2004 to 2013
$5.6M
PROMIS Technical CenterU54AR057943 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GERSHON, RICHARD · 2009 to 2013
$5.3M
UW Center on Outcomes Research in Rehabilitation(RMI)U01AR052171 · NIAMS · UNIVERSITY OF WASHINGTON · PI AMTMANN, DAGMAR · 2004 to 2008
$5.0M
Pediatric PROMIS: Advancing the Measurement and Conceptualizaiton of Child HealthU01AR057956 · NIAMS · CHILDREN'S HOSP OF PHILADELPHIA · PI FORREST, CHRISTOPHER B · 2009 to 2014
$4.9M
Ecolog validity- patient-reported chronic disease*(RMI)U01AR052170 · NIAMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI STONE, ARTHUR A · 2004 to 2008
$3.8M
NCI NIH HHS U2C CA186878NCI NIH HHS U2CCA186878NIAMS NIH HHS U01 AR052155NIAMS NIH HHS U01 AR052158NIAMS NIH HHS U01 AR052170NIAMS NIH HHS U01 AR052171NIAMS NIH HHS U01 AR052177NIAMS NIH HHS U01 AR052181NIAMS NIH HHS U01AR052181NIAMS NIH HHS U01 AR052186NIAMS NIH HHS U01 AR057929NIAMS NIH HHS U01 AR057936NIAMS NIH HHS U01 AR057940NIAMS NIH HHS U01 AR057948NIAMS NIH HHS U01 AR057954NIAMS NIH HHS U01 AR057956NIAMS NIH HHS U01 AR057967NIAMS NIH HHS U01 AR057971NIAMS NIH HHS U54 AR057926NIAMS NIH HHS U54 AR057943NIAMS NIH HHS U54 AR057951NLM NIH HHS T32 LM012420
6 · The paper itself

Abstract

purposePrevious studies provided evidence for the validity of the PROMIS Pediatric measures in cross-sectional studies. This study evaluated the ability of the PROMIS Pediatric measures to detect change over time in children and adolescents with cancer, nephrotic syndrome (NS), or sickle cell disease (SCD).

methodsParticipants (8-17 years) completed measures of fatigue, pain interference, anger, anxiety, depressive symptoms, mobility, upper extremity, and peer relationships at three or four time points (T1-T4). Between T1 and T2, children with cancer received chemotherapy and children with SCD experienced a pain exacerbation. Children with NS were first assessed during active disease (T2), with T3 and T4 conducted at disease remission. For the primary analysis of responsiveness, we expected better scores at T3 (recovery) compared to T2 (event) for all diseases. T1 and T4 are also expected to have better scores than T2. Linear mixed models were used and adjusted for time, gender, age, race/ethnicity, education, comorbid conditions, and disease.

resultsEnrolled were 96 children with cancer, 121 children with SCD, and 127 children with NS. Fatigue, pain interference, mobility, and upper extremity scores worsened from T1 (baseline) to T2 (event) (p < 0.01), and significantly improved from T2 to T3 and T4 (p < 0.01). Similarly, anxiety and depressive symptoms significantly improved from T2 to T3 and T4 (p < 0.01).

conclusionsThis study provides evidence for the responsiveness of seven PROMIS Pediatric measures to clinical disease state in three chronic illnesses. The findings support use of PROMIS Pediatric measures in clinical research.

Indexed as

AdolescentAnemia, Sickle CellChildCross-Sectional StudiesFemaleHumansMaleNeoplasmsNephrotic SyndromeQuality of LifeSelf ReportSurveys and QuestionnairesCancerNephrotic syndromePatient-reported outcomesPediatricsResponsivenessSickle cell disease

Identifiers

PMID28884421
PMCPMC5771815
OpenAlexW2753126679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.